IE
GNOM icon

Israel Englander’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Israel Englander’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,664
Closed -$123K – 6349
2023
Q4 		$123K Buy
+2,664
New +$109K ﹤0.01% 5293

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Israel Englander's GNOM Position: Q1 2024 in Review

Israel Englander sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2024, closing a stake of 2,664 shares — an estimated $123K sold.

Israel Englander first reported a position in GNOM in Q4 2023 and held it in 1 quarter. The position peaked at $123K in Q4 2023. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2024.

  • Israel Englander reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
  • Israel Englander sold 2,664 Global X Genomics & Biotechnology ETF shares in Q1 2024, an estimated $123K.
  • Israel Englander first reported a position in Global X Genomics & Biotechnology ETF in Q4 2023 and held it in 1 quarter.
  • Israel Englander's Global X Genomics & Biotechnology ETF position peaked at $123K in Q4 2023.
  • 60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.